InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,568.64
(
0.08%
)
US TECH 100
19,261.24
(
-0.23%
)
Dow Jones
40,483.07
(
0.17%
)
Brent Oil
80.59
(
-1.13%
)
Bitcoin
66,066.91
(
-2.27%
)
Post# of 252652
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120095
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 210558

Thursday, 05/23/2019 4:36:13 PM

Thursday, May 23, 2019 4:36:13 PM

Post# of 252652
ONVO -39% on this gem in FY4Q19 PR:

https://finance.yahoo.com/news/organovo-updates-key-clinical-development-200500692.html

“We have determined that we need to conduct additional preclinical studies, optimize our manufacturing processes, and most importantly to generate decisive scientific data regarding the prolonged functionality and therapeutic benefits of our liver tissue patch,” said Taylor J. Crouch, CEO, Organovo.

Those with a long memory may know that Crouch was the CEO of Variagenics.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up